BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 24881813)

  • 1. Epigenetic landscape during osteoblastogenesis defines a differentiation-dependent Runx2 promoter region.
    Tai PW; Wu H; Gordon JA; Whitfield TW; Barutcu AR; van Wijnen AJ; Lian JB; Stein GS; Stein JL
    Gene; 2014 Oct; 550(1):1-9. PubMed ID: 24881813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dlx5 specifically regulates Runx2 type II expression by binding to homeodomain-response elements in the Runx2 distal promoter.
    Lee MH; Kim YJ; Yoon WJ; Kim JI; Kim BG; Hwang YS; Wozney JM; Chi XZ; Bae SC; Choi KY; Cho JY; Choi JY; Ryoo HM
    J Biol Chem; 2005 Oct; 280(42):35579-87. PubMed ID: 16115867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic Signatures at the RUNX2-P1 and Sp7 Gene Promoters Control Osteogenic Lineage Commitment of Umbilical Cord-Derived Mesenchymal Stem Cells.
    Sepulveda H; Aguilar R; Prieto CP; Bustos F; Aedo S; Lattus J; van Zundert B; Palma V; Montecino M
    J Cell Physiol; 2017 Sep; 232(9):2519-2527. PubMed ID: 27689934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-stimulation of the bone-related Runx2 P1 promoter in mesenchymal cells by SP1 and ETS transcription factors at polymorphic purine-rich DNA sequences (Y-repeats).
    Zhang Y; Hassan MQ; Xie RL; Hawse JR; Spelsberg TC; Montecino M; Stein JL; Lian JB; van Wijnen AJ; Stein GS
    J Biol Chem; 2009 Jan; 284(5):3125-3135. PubMed ID: 19017640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SWI/SNF-independent nuclease hypersensitivity and an increased level of histone acetylation at the P1 promoter accompany active transcription of the bone master gene Runx2.
    Cruzat F; Henriquez B; Villagra A; Hepp M; Lian JB; van Wijnen AJ; Stein JL; Imbalzano AN; Stein GS; Montecino M
    Biochemistry; 2009 Aug; 48(30):7287-95. PubMed ID: 19545172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HOXA10 controls osteoblastogenesis by directly activating bone regulatory and phenotypic genes.
    Hassan MQ; Tare R; Lee SH; Mandeville M; Weiner B; Montecino M; van Wijnen AJ; Stein JL; Stein GS; Lian JB
    Mol Cell Biol; 2007 May; 27(9):3337-52. PubMed ID: 17325044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The bone-specific Runx2-P1 promoter displays conserved three-dimensional chromatin structure with the syntenic Supt3h promoter.
    Barutcu AR; Tai PW; Wu H; Gordon JA; Whitfield TW; Dobson JR; Imbalzano AN; Lian JB; van Wijnen AJ; Stein JL; Stein GS
    Nucleic Acids Res; 2014; 42(16):10360-72. PubMed ID: 25120271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the Runx2 promoter in osseous and non-osseous cells and identification of HIF2A as a potent transcription activator.
    Tamiya H; Ikeda T; Jeong JH; Saito T; Yano F; Jung YK; Ohba S; Kawaguchi H; Chung UI; Choi JY
    Gene; 2008 Jun; 416(1-2):53-60. PubMed ID: 18442887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic Control of the Bone-master Runx2 Gene during Osteoblast-lineage Commitment by the Histone Demethylase JARID1B/KDM5B.
    Rojas A; Aguilar R; Henriquez B; Lian JB; Stein JL; Stein GS; van Wijnen AJ; van Zundert B; Allende ML; Montecino M
    J Biol Chem; 2015 Nov; 290(47):28329-28342. PubMed ID: 26453309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MAP Kinase-Dependent RUNX2 Phosphorylation Is Necessary for Epigenetic Modification of Chromatin During Osteoblast Differentiation.
    Li Y; Ge C; Franceschi RT
    J Cell Physiol; 2017 Sep; 232(9):2427-2435. PubMed ID: 27514023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteogenic differentiation of C2C12 myogenic progenitor cells requires the Fos-related antigen Fra-1 - a novel target of Runx2.
    Yu S; Geng Q; Sun F; Yu Y; Pan Q; Hong A
    Biochem Biophys Res Commun; 2013 Jan; 430(1):173-8. PubMed ID: 23159633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mll-COMPASS complexes mediate H3K4me3 enrichment and transcription of the osteoblast master gene Runx2/p57 in osteoblasts.
    Rojas A; Sepulveda H; Henriquez B; Aguilar R; Opazo T; Nardocci G; Bustos F; Lian JB; Stein JL; Stein GS; van Zundert B; van Wijnen AJ; Allende ML; Montecino M
    J Cell Physiol; 2019 May; 234(5):6244-6253. PubMed ID: 30256410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dlx5 and mef2 regulate a novel runx2 enhancer for osteoblast-specific expression.
    Kawane T; Komori H; Liu W; Moriishi T; Miyazaki T; Mori M; Matsuo Y; Takada Y; Izumi S; Jiang Q; Nishimura R; Kawai Y; Komori T
    J Bone Miner Res; 2014 Sep; 29(9):1960-9. PubMed ID: 24692107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide DNase hypersensitivity, and occupancy of RUNX2 and CTCF reveal a highly dynamic gene regulome during MC3T3 pre-osteoblast differentiation.
    Tai PWL; Wu H; van Wijnen AJ; Stein GS; Stein JL; Lian JB
    PLoS One; 2017; 12(11):e0188056. PubMed ID: 29176792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycystin-1 regulates skeletogenesis through stimulation of the osteoblast-specific transcription factor RUNX2-II.
    Xiao Z; Zhang S; Magenheimer BS; Luo J; Quarles LD
    J Biol Chem; 2008 May; 283(18):12624-34. PubMed ID: 18321855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic occupancy of Runx2 with global expression profiling identifies a novel dimension to control of osteoblastogenesis.
    Wu H; Whitfield TW; Gordon JA; Dobson JR; Tai PW; van Wijnen AJ; Stein JL; Stein GS; Lian JB
    Genome Biol; 2014 Mar; 15(3):R52. PubMed ID: 24655370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic occupancy of HLH, AP1 and Runx2 motifs within a nuclease sensitive site of the Runx2 gene.
    Hovhannisyan H; Zhang Y; Hassan MQ; Wu H; Glackin C; Lian JB; Stein JL; Montecino M; Stein GS; van Wijnen AJ
    J Cell Physiol; 2013 Feb; 228(2):313-21. PubMed ID: 22886425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the ectodomain-releasing protease ADAM17 is directly regulated by the osteosarcoma and bone-related transcription factor RUNX2.
    Araya HF; Sepulveda H; Lizama CO; Vega OA; Jerez S; Briceño PF; Thaler R; Riester SM; Antonelli M; Salazar-Onfray F; Rodríguez JP; Moreno RD; Montecino M; Charbonneau M; Dubois CM; Stein GS; van Wijnen AJ; Galindo MA
    J Cell Biochem; 2018 Nov; 119(10):8204-8219. PubMed ID: 29923217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EZH2 or HDAC1 Inhibition Reverses Multiple Myeloma-Induced Epigenetic Suppression of Osteoblast Differentiation.
    Adamik J; Jin S; Sun Q; Zhang P; Weiss KR; Anderson JL; Silbermann R; Roodman GD; Galson DL
    Mol Cancer Res; 2017 Apr; 15(4):405-417. PubMed ID: 28119431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C/EBPβ binds the P1 promoter of the Runx2 gene and up-regulates Runx2 transcription in osteoblastic cells.
    Henriquez B; Hepp M; Merino P; Sepulveda H; van Wijnen AJ; Lian JB; Stein GS; Stein JL; Montecino M
    J Cell Physiol; 2011 Nov; 226(11):3043-52. PubMed ID: 21302301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.